Saltar al contenido

Francesco Bertoni

@frbertoni.bsky.social did:plc:am3g2x2ua4npyujnygdinh32

Institute of Oncology Research. President, ICML Local Organizing Committee. USI. Personal opinions only. #lymsm #lymphoma

En Bluesky desde el

Seguidores
130
Siguiendo
190
Posts
65
Días en rankings
0

Resumen

Francesco Bertoni (@frbertoni.bsky.social) es un usuario de Bluesky que se unió el 15 abril 2025. Tiene 130 seguidores, sigue a 190 cuentas y ha publicado 65 posts.

Apariciones en rankings

Los mejores días en que los posts de esta cuenta entraron en la lista diaria de Debya.

Esta cuenta aún no ha aparecido en un ranking diario.

Posts que le gustaron recientemente

Me gusta públicos de la red Bluesky.

  • American Association for Cancer Research (AACR)@theaacr.bsky.social

    Shannon Buckley, Francesco Bertoni, and Justin Taylor discussed "Degraders in Lymphoma" during a plenary session at the AACR Conference on Advances in Malignant Lymphoma. #AACRlymphoma26 @frbertoni.bsky.social

    Ver post
  • American Association for Cancer Research (AACR)@theaacr.bsky.social

    Degraders in Lymphoma: Shannon Buckley, Francesco Bertoni, and Justin Taylor will address this topic in a plenary session at the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia). Learn more: buff.ly/XH3lbfr #AACRlymphoma26 @frbertoni.bsky.social

    Ver post
  • Institute of Oncology Research (IOR)@iorbellinzona.bsky.social

    #IORnews 🌊 Researchers from the IOR and the University of Galway in Ireland have identified a new natural compound from Irish marine life showing strong potential against an aggressive, hard-to-treat form of blood cancer. Learn more: ior.usi.ch/events-news/...

    Ver post
  • International Conference on Malignant Lymphoma@icmlugano.bsky.social

    Yesterday we had our first 19-ICML Local Organising Committee meeting — the behind-the-scenes work for the next edition has officially begun! 💥 @frbertoni.bsky.social #19ICML #ICML #lymphoma #CLL #myeloma #lymssm

    Ver post
  • Institute of Oncology Research (IOR)@iorbellinzona.bsky.social

    #IORnews A collaborative team from IOR, Dana-Farber Cancer Institute (Harvard Medical School), and biotech iOnctura reports that the novel drug roginolisib may boost the effectiveness of venetoclax in blood cancers such as DLBCL, mantle cell lymphoma, and CLL. Learn more: tinyurl.com/ytybcbr8

    Ver post

Inicia sesión para ver más

Cuentas que bloquea

En Bluesky los bloqueos son registros públicos.